Robin Harper Cowie of Biodesix, Inc. and Lyndsey Linke of SiVEC Biotechnologies, Inc. Represent the Momentum of State’s Life Sciences Community

Denver – Colorado BioScience Association (CBSA), which creates co-opportunity for Colorado’s life sciences community by championing a collaborative life sciences ecosystem and advocating for a supportive business climate, announced the appointment of two new board of directors members. Robin Harper Cowie, Chief Financial Officer and Chief Compliance Officer of Biodesix, Inc. and Lyndsey Linke, Chief Executive Officer and Co-Founder of SiVEC Biotechnologies, Inc. were appointed to the CBSA Board of Directors at the annual board retreat on April 27.

Selected for their leadership in growing successful organizations with products designed to save and change patient lives around the world, the incoming board members are respected leaders in the state’s life sciences community.

Robin Harper Cowie, Chief Financial Officer and Chief Compliance Officer, Biodesix, Inc. (Boulder)

Offers broad expertise in corporate strategy and growth for a publicly traded diagnostics company. Her track record of success includes fundraising, M&A, reimbursement, operations, and compliance. Robin has raised capital through an IPO, public follow-ons, private financing, and debt offerings. Biodesix is a leading data-driven diagnostic solutions company focused on lung disease.

Lyndsey Linke, Ph.D., M.E., Chief Executive Officer and Co-Founder, SiVEC Biotechnologies, Inc. (Fort Collins)

Brings deep expertise in technology transfer, company formation, and successful fundraising. Lyndsey has secured significant state and federal grants and was honored as the Top Emerging Company at the 2022 BIO International Convention. SiVEC Biotechnologies spun out from Colorado State University in 2016. The company has developed a tissue-specific drug delivery platform to enable the next generation of nucleic acid and gene therapies and is developing first-in-class assets targeting respiratory, oncology, and genetic diseases.

“CBSA welcomes these dynamic leaders who represent the momentum and depth of our life sciences community to our board of directors,” said Kiki Traylor, M.D., CBSA Board of Directors Chair and Amgen Director of State Government Affairs. “Robin and Lyndsey are visionary health innovators who are passionate about building and growing successful life sciences companies in Colorado.”     

Additionally, CBSA expanded its executive committee to include leaders of board-level committees.

CBSA Board of Directors Executive Committee:

Kathleen (Kiki) Traylor, M.D., Amgen – Chair

Ethan Mann, Validus Cellular Therapeutics – Vice Chair

Robert Reddy, Medtronic – Past Chair

Alan Rudolph, Colorado State University – Secretary

Jim Wilson Ernst & Young – Treasurer + Finance & Audit Committee Chair

Dan Wittenberg, Snell & Wilmer – Governance Committee Chair

Terry Dagnon, Outlook Therapeutics – Nominating Committee Chair

Rita Sanzgiri, J.D., Eli Lilly – DEI Committee Chair

Byron Hewett, HepQuant/General Inception – Strategic Planning Committee Chair

April Giles, Fitzsimons Innovation Community – Development Committee Chair

“CBSA taps the strength and experience of Colorado’s life sciences leaders to advance our organization, support our members, and accelerate our work to become a leading U.S. hub for life sciences,” said Elyse Blazevich, President and CEO of Colorado BioScience Association. “With Capital + Growth a top priority for our ecosystem, we are honored to welcome Robin and Lyndsey, who represent the breadth of fundraising expertise, from concept to commercialization, to our board.”  

Thirty board members representing medical device and diagnostics, pharmaceuticals, ag bio and animal health, digital health, academic and research institutions, and service providers make up the CBSA board. Board members work in partnership with CBSA staff to support the growth of Colorado’s more than 720 life sciences companies. Names and photos of the full board of directors are available on the CBSA website.   

About Colorado BioScience Association

Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com

# # #

Media Contact

Sheliah Reynolds

Primavera Group for Colorado BioScience Association

(720) 289-4739

sheliah@theprimaveragroup.com